"Standard" branded generic medicines excluded from PPRS

Following the public consultation foreseen in the 2005 Pharmaceutical Price Regulation Scheme (PPRS) agreement, the Department of Health (DoH) has concluded that standard branded generic medicines are to be removed from the PPRS and are to be reimbursed at the lesser of the Drug Tariff price of the comparable true generic or the list price of the standard branded generic medicine. The DoH is undertaking two further consultations to deal with concerns on accuratley identifying such generic medicines. The first of these consultations seeks views on the list of oral solid dose products to be classified as standard branded generics and, therefore, to be removed from the PPRS, and on some finer details of the arrangements for their reimbursement (reponses by 24 October 2005). The second consultation, to focus on identifying non-oral solid dose standard branded generic medicines, will be done in 2006.

Filed under Department of Health, Healthcare, Pharmaceuticals.

Reckon LLP is an economics consultancy with expertise in data analysis, economic regulation and competition law.

About Reckon